Intravenous Interferon β-1a for Severe ARDS-Reply

JAMA. 2020 Aug 4;324(5):515-516. doi: 10.1001/jama.2020.7992.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Administration, Intravenous
  • Humans
  • Interferon beta-1a
  • Interferon-beta
  • Multiple Sclerosis, Relapsing-Remitting*
  • Respiratory Distress Syndrome*

Substances

  • Interferon-beta
  • Interferon beta-1a